Company registration number SC549701 (Scotland)
BETTER NUTRITIONAL SCIENCE LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2025
PAGES FOR FILING WITH REGISTRAR
BETTER NUTRITIONAL SCIENCE LTD
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 9
BETTER NUTRITIONAL SCIENCE LTD
BALANCE SHEET
AS AT 30 NOVEMBER 2025
30 November 2025
- 1 -
2025
2024
as restated
Notes
£
£
£
£
Fixed assets
Tangible assets
4
2,029,875
1,871,638
Current assets
Stocks
55,000
88,184
Debtors
5
219,001
20,473
Cash at bank and in hand
110,684
161,203
384,685
269,860
Creditors: amounts falling due within one year
6
(2,163,789)
(2,125,138)
Net current liabilities
(1,779,104)
(1,855,278)
Total assets less current liabilities
250,771
16,360
Provisions for liabilities
(34,293)
-
Net assets
216,478
16,360
Capital and reserves
Called up share capital
51
51
Revaluation reserve
7
175,398
-
0
Profit and loss reserves
41,029
16,309
Total equity
216,478
16,360
BETTER NUTRITIONAL SCIENCE LTD
BALANCE SHEET (CONTINUED)
AS AT 30 NOVEMBER 2025
30 November 2025
- 2 -

For the financial year ended 30 November 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 15 February 2026 and are signed on its behalf by:
Ms Y Tung
Mr C Scott
Director
Director
Company registration number SC549701 (Scotland)
BETTER NUTRITIONAL SCIENCE LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2025
- 3 -
1
Accounting policies
Company information

Better Nutritional Science Ltd is a private company limited by shares incorporated in Scotland. The registered office is 5 Coates Crescent, Edinburgh, EH3 7AL.

1.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, [modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value]. The principal accounting policies adopted are set out below.

1.2
Revenue

Revenue comprises sales of goods or services provided to customers net of value added tax and other sales taxes, less an appropriate deduction for actual and expected returns and discounts. Revenue is recognised when performance obligations are satisfied and the control of goods or services is transferred to the buyer. Where the performance obligation is satisfied over time, revenue is recognised in accordance with its progress towards complete satisfaction of that performance obligation.

 

When cash inflows are deferred and represent a financing arrangement, the promised consideration is adjusted for the effects of the time value of money, which is recognised as interest income.

The company recognises revenue from the following major sources:

The nature, timing of satisfaction of performance obligations and significant payment terms of the company's major sources of revenue are as follows:

Global B2B of Nutritional Supplements

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that are recoverable.

1.3
Research and development expenditure

Research expenditure is written off against profits in the year in which it is incurred. Identifiable development expenditure is capitalised to the extent that the technical, commercial and financial feasibility can be demonstrated.

BETTER NUTRITIONAL SCIENCE LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2025
1
Accounting policies
(Continued)
- 4 -
1.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Freehold land and buildings
3% on cost
Fixtures and fittings
25% on cost
Computers
25% on cost

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

 

1.5
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted. If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

1.6
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

 

Stocks held for distribution at no or nominal consideration are measured at the lower of cost and replacement cost, adjusted where applicable for any loss of service potential.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

BETTER NUTRITIONAL SCIENCE LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2025
1
Accounting policies
(Continued)
- 5 -
1.7
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.8
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.9
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.10
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

BETTER NUTRITIONAL SCIENCE LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2025
1
Accounting policies
(Continued)
- 6 -
Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.11
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.12
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

BETTER NUTRITIONAL SCIENCE LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2025
- 7 -
3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
11
11
4
Tangible fixed assets
Land and buildings
Plant and machinery etc
Total
£
£
£
Cost or valuation
At 1 December 2024
2,010,655
74,143
2,084,798
Additions
6,000
24,743
30,743
Revaluation
209,691
-
0
209,691
At 30 November 2025
2,226,346
98,886
2,325,232
Depreciation and impairment
At 1 December 2024
165,846
47,314
213,160
Depreciation charged in the year
60,500
21,697
82,197
At 30 November 2025
226,346
69,011
295,357
Carrying amount
At 30 November 2025
2,000,000
29,875
2,029,875
At 30 November 2024
1,844,809
26,829
1,871,638

Freehold land and buildings with a carrying amount of £2,000,000 (2024 - £1,844,809) have been pledged to secure borrowings of the company. The company is not allowed to pledge these assets as security for other borrowings or to sell them to another entity.

Land and buildings with a carrying amount of £1,844,809 were revalued at 30 November 2025 by the director on the basis of market value. The revaluation was based on recent market transactions on arm's length terms for similar properties.

BETTER NUTRITIONAL SCIENCE LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2025
4
Tangible fixed assets
(Continued)
- 8 -

The following assets are carried at valuation. If the assets were measured using the cost model, the carrying amounts would be as follows:

Land and buildings
2025
2024
£
£
Cost
2,016,655
2,010,655
Accumulated depreciation
(226,346)
(165,846)
Carrying value
1,790,309
1,844,809
5
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
213,498
15,847
Other debtors
5,503
4,626
219,001
20,473
6
Creditors: amounts falling due within one year
2025
2024
£
£
Bank loans and overdrafts
878,408
826,508
Trade creditors
209
17,295
Taxation and social security
7,305
231
Other creditors
1,277,867
1,281,104
2,163,789
2,125,138
7
Revaluation reserve
2025
2024
£
£
At the beginning of the year
-
0
-
0
Revaluation surplus arising in the year
175,398
-
0
At the end of the year
175,398
-
BETTER NUTRITIONAL SCIENCE LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2025
- 9 -
8
Prior period adjustment

During the preparation of the financial statements for the year ended 30 November 2025, errors were identified in the accounting treatment of certain expenses, prepayments, accruals and liabilities relating to previous accounting periods. The errors principally related to wages, insurance, telecommunications, cost of goods sold, royalty charges, rates and delivery costs. The errors have been corrected retrospectively in accordance with Section 10 of FRS 102 and the comparative figures have been restated accordingly.

Reconciliation of changes in equity
1 December
30 November
2023
2024
£
£
Adjustments to prior year
Correction of errors arising before 1 December 2023
22,077
22,077
Correction of delivery costs in year ended 30 November 2024
-
7,946
Total adjustments
22,077
30,023
Equity as previously reported
115,845
(13,663)
Equity as adjusted
137,922
16,360
Analysis of the effect upon equity
Profit and loss reserves
22,077
30,023
Reconciliation of changes in loss for the previous financial period
2024
£
Adjustments to prior year
Correction of delivery costs in year ended 30 November 2024
7,946
Loss as previously reported
(70,302)
Loss as adjusted
(62,356)
Notes to reconciliation

Correction of errors relating to accounting periods prior to 1 December 2023, resulting in an increase in opening retained earnings of £22,077 before taxation.

Correction of delivery costs previously overstated in the year ended 30 November 2024, resulting in a reduction in cost of sales and the loss for the year of £7,946.

2025-11-302024-12-01falsefalsefalse15 February 2026CCH SoftwareCCH Accounts Production 2026.200No description of principal activityMs Y TungMr C ScottSC5497012024-12-012025-11-30SC5497012025-11-30SC5497012024-11-30SC549701core:WithinOneYear2025-11-30SC549701core:WithinOneYear2024-11-30SC549701core:CurrentFinancialInstrumentscore:WithinOneYear2025-11-30SC549701core:CurrentFinancialInstrumentscore:WithinOneYear2024-11-30SC549701core:ShareCapital2025-11-30SC549701core:ShareCapital2024-11-30SC549701core:RevaluationReserve2025-11-30SC549701core:RevaluationReserve2024-11-30SC549701core:RetainedEarningsAccumulatedLosses2025-11-30SC549701core:RetainedEarningsAccumulatedLosses2024-11-30SC549701core:RevaluationReserve2024-11-30SC549701core:RevaluationReserve2023-11-30SC549701bus:Director12024-12-012025-11-30SC549701bus:Director22024-12-012025-11-30SC549701core:LandBuildingscore:OwnedOrFreeholdAssets2024-12-012025-11-30SC549701core:FurnitureFittings2024-12-012025-11-30SC549701core:ComputerEquipment2024-12-012025-11-30SC5497012023-12-012024-11-30SC549701core:LandBuildings2024-11-30SC549701core:OtherPropertyPlantEquipment2024-11-30SC5497012024-11-30SC549701core:LandBuildings2025-11-30SC549701core:OtherPropertyPlantEquipment2025-11-30SC549701core:LandBuildings2024-12-012025-11-30SC549701core:OtherPropertyPlantEquipment2024-12-012025-11-30SC549701core:LandBuildings2024-11-30SC549701core:OtherPropertyPlantEquipment2024-11-30SC549701core:CurrentFinancialInstruments2025-11-30SC549701core:CurrentFinancialInstruments2024-11-30SC549701core:RevaluationReserve2024-12-012025-11-30SC549701bus:PrivateLimitedCompanyLtd2024-12-012025-11-30SC549701bus:SmallCompaniesRegimeForAccounts2024-12-012025-11-30SC549701bus:FRS1022024-12-012025-11-30SC549701bus:AuditExemptWithAccountantsReport2024-12-012025-11-30SC549701bus:FullAccounts2024-12-012025-11-30xbrli:purexbrli:sharesiso4217:GBP